{"id":7952,"date":"2013-06-27T19:42:17","date_gmt":"2013-06-27T19:42:17","guid":{"rendered":"http:\/\/goldstocksforex.com\/?page_id=7952"},"modified":"2021-11-08T02:58:53","modified_gmt":"2021-11-08T02:58:53","slug":"my-strategy","status":"publish","type":"page","link":"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/","title":{"rendered":"Our Strategy"},"content":{"rendered":"<h2>Investment Allocation<\/h2>\n<p><strong>We invest primarily in growth stocks<\/strong> but at times will supplement these with more mature, lower growth dividend stocks or cyclicals.<\/p>\n<h3>Growth Stocks<\/h3>\n<p>We invest in growth stocks that stand to benefit from long-term (secular) trends expected to last a generation or more. Trends include the growth of renewable energy; online services; artificial intelligence; the Internet of Things; cyber-security; medical technology; ageing populations in developed economies and China; and an expanding Asian middle class.<\/p>\n<p>We focus on sector opportunities from long-term trends that offer attractive growth opportunities and identify stocks that display:<\/p>\n<ul>\n<li>Strong earnings growth; and<\/li>\n<li>Ability to defend their market position against competitors.<\/li>\n<\/ul>\n<p>Allocation to growth stocks may at times be as high as 95% of portfolio value.<\/p>\n<h3>Dividends &amp; Growth<\/h3>\n<p>We sometimes invest in mature stocks with lower growth prospects if there are strong distributions to shareholders, through dividends or buybacks, and attractive fair value.<\/p>\n<p>Allocation is limited to a maximum of 30% of portfolio value.<\/p>\n<h3>Cyclicals<\/h3>\n<p>We also at times invest in cyclical stocks if we expect strong appreciation. This includes gold miners, physical gold &amp; precious metals, oil &amp; gas, metals &amp; mining, and construction materials.<\/p>\n<p>Total cyclical allocation is limited to a maximum of 30% of portfolio value.<\/p>\n<h3>Cash &amp; Fixed Income<\/h3>\n<p>We maintain a minimum 5% cash balance in the portfolio to cover contingencies.<\/p>\n<p>Fixed income includes term deposits, fixed interest ETFs, corporate bonds and mortgages.<\/p>\n<p>Allocation to this sector will vary depending on our assessment of market risk. <strong>At times of elevated risk, cash and fixed income may exceed 70% of portfolio value.<\/strong><\/p>\n<h2>Investment Selection<\/h2>\n<p>We use both technical and fundamental analysis to select stocks for investment.<\/p>\n<p><strong>We only buy stocks that have both a favorable fair value and a bullish technical outlook<\/strong>. As a general rule, we also only sell stocks when both fair value and the technical outlook are bearish. The exception to the sell rule is when we decide that global market risk is elevated and seek to reduce overall exposure to equities.<\/p>\n<h3>Fair Value<\/h3>\n<p>We calculate the fair value of stocks based on expected future cash flows using our proprietary <a href=\"https:\/\/thepatientinvestor.com\/index.php\/payback-period\/\">payback formula<\/a>.<\/p>\n<h3>Technical Outlook<\/h3>\n<p>We assess the technical outlook using proprietary Momentum and Buy\/Sell indicators.<\/p>\n<h5>Next<\/h5>\n<ul style=\"list-style-type: none;\">\n<li><a href=\"https:\/\/thepatientinvestor.com\/index.php\/investment-allocation\/\">Current Investment Allocation &amp; History<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Investment Allocation We invest primarily in growth stocks but at times will supplement these with more mature, lower growth dividend stocks or cyclicals. Growth Stocks We invest in growth stocks that stand to benefit from long-term (secular) trends expected to last a generation or more. Trends include the growth of renewable energy; online services; artificial &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Our Strategy&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mo_disable_npp":"","footnotes":""},"class_list":["post-7952","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Our Strategy - the patient investor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Our Strategy - the patient investor\" \/>\n<meta property=\"og:description\" content=\"Investment Allocation We invest primarily in growth stocks but at times will supplement these with more mature, lower growth dividend stocks or cyclicals. Growth Stocks We invest in growth stocks that stand to benefit from long-term (secular) trends expected to last a generation or more. Trends include the growth of renewable energy; online services; artificial &hellip; Continue reading &quot;Our Strategy&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-08T02:58:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/my-strategy\\\/\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/my-strategy\\\/\",\"name\":\"Our Strategy - the patient investor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\"},\"datePublished\":\"2013-06-27T19:42:17+00:00\",\"dateModified\":\"2021-11-08T02:58:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/my-strategy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/my-strategy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/my-strategy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/thepatientinvestor.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Strategy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thepatientinvestor.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61572934660810\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Our Strategy - the patient investor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/","og_locale":"en_US","og_type":"article","og_title":"Our Strategy - the patient investor","og_description":"Investment Allocation We invest primarily in growth stocks but at times will supplement these with more mature, lower growth dividend stocks or cyclicals. Growth Stocks We invest in growth stocks that stand to benefit from long-term (secular) trends expected to last a generation or more. Trends include the growth of renewable energy; online services; artificial &hellip; Continue reading \"Our Strategy\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_modified_time":"2021-11-08T02:58:53+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/","url":"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/","name":"Our Strategy - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"datePublished":"2013-06-27T19:42:17+00:00","dateModified":"2021-11-08T02:58:53+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/my-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Our Strategy"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]}]}},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/P9tQ4n-24g","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":16902,"url":"https:\/\/thepatientinvestor.com\/index.php\/what-to-look-for-in-a-stock-update\/","url_meta":{"origin":7952,"position":0},"title":"What to look for in a Stock Update","author":"Colin Twiggs","date":"August 27, 2018","format":false,"excerpt":"Here is a brief summary of what to look for in a stock report. Structural or Cyclical Trends First prize is to find a growth stock with a multi-decade structural trend that will boost revenue and earnings growth. Whether from the rapid growth of technology, online services, artificial intelligence, ageing\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":20343,"url":"https:\/\/thepatientinvestor.com\/index.php\/my-portfolios\/investment-allocation\/","url_meta":{"origin":7952,"position":1},"title":"Investment Allocation","author":"Colin Twiggs","date":"April 22, 2020","format":false,"excerpt":"Current portfolio allocations differ considerably from our target allocations, set as a long-term aspirational goal, due to elevated market risk, over-priced sectors, and opportunities in cyclicals (including gold and precious metals). Allocations Changed Apr-2023 We have revised the allocation of some stocks held in the model portfolios. These changes have\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":45360,"url":"https:\/\/thepatientinvestor.com\/index.php\/moderate-portfolio\/","url_meta":{"origin":7952,"position":2},"title":"Moderate Portfolio","author":"Colin Twiggs","date":"November 12, 2023","format":false,"excerpt":"A mix of Australian and International stocks selected for investors with a moderate risk profile. Details of our broad strategy were posted on October 20, 2023. We have since updated our long-term goal, with a greater emphasis on diversified allocation to high-quality global stocks. So far, there are two additions\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2018\/09\/pdf_32.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":16394,"url":"https:\/\/thepatientinvestor.com\/index.php\/my-portfolios\/","url_meta":{"origin":7952,"position":3},"title":"Model Portfolios","author":"Colin Twiggs","date":"July 2, 2018","format":false,"excerpt":"We run two model portfolios based on our investment strategy: International Growth consists mainly of growth stocks listed on the NYSE\/Nasdaq, and includes many multinationals, but may include stocks listed elsewhere and at times will include cyclical stocks or ETFs (e.g. gold). Australian Growth is a far more diverse portfolio,\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":17067,"url":"https:\/\/thepatientinvestor.com\/index.php\/gordon-growth-model\/","url_meta":{"origin":7952,"position":4},"title":"Gordon Growth Model","author":"Colin Twiggs","date":"September 18, 2018","format":false,"excerpt":"The Gordon Growth Model is named after economist Myron J. Gordon of the University of Toronto, who originally published the model along with Eli Shapiro in 1956. Also known as the Dividend Discount Model, Gordon's model is used for valuing stocks that pay regular dividends that are expected to grow\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":17296,"url":"https:\/\/thepatientinvestor.com\/index.php\/international-growth-portfolio\/","url_meta":{"origin":7952,"position":5},"title":"International Portfolio","author":"Colin Twiggs","date":"November 5, 2018","format":false,"excerpt":"Current Recommendations Here is a summary of our latest recommendations for the International1 Portfolio: International 20220224.pdf We reduced exposure to lithium miner Albemarle (ALB.NY) to 5% of portfolio value after a strong recovery in lithium prices. We added two more defensive stocks to the portfolio: Ambev SA ADR (ABEV.NY) Infrastrutture\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2018\/09\/pdf_32.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/pages\/7952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=7952"}],"version-history":[{"count":35,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/pages\/7952\/revisions"}],"predecessor-version":[{"id":28775,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/pages\/7952\/revisions\/28775"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=7952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}